Drug Type Small molecule drug |
Synonyms APH-0804 |
Target |
Action inhibitors |
Mechanism TDP1 inhibitors(tyrosyl-DNA phosphodiesterase 1 inhibitors), TOP1 inhibitors(DNA topoisomerase I inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colonic Cancer | Preclinical | United States | 01 Sep 2025 | |
| Lung Cancer | Preclinical | United States | 01 Sep 2025 | |
| Ovarian Cancer | Preclinical | United States | 01 Sep 2025 | |
| Neoplasms | Discovery | United States | - |





